Free Trial

GAMMA Investing LLC Raises Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Pediatrix Medical Group logo with Medical background

GAMMA Investing LLC grew its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 4,530.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,225 shares of the company's stock after buying an additional 36,421 shares during the quarter. GAMMA Investing LLC's holdings in Pediatrix Medical Group were worth $539,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in MD. Nomura Asset Management Co. Ltd. raised its position in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after acquiring an additional 1,220 shares in the last quarter. Parkside Financial Bank & Trust raised its position in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after acquiring an additional 1,040 shares in the last quarter. AlphaQuest LLC raised its position in shares of Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after acquiring an additional 2,012 shares in the last quarter. Smartleaf Asset Management LLC raised its position in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after acquiring an additional 6,090 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its position in shares of Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after acquiring an additional 5,104 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Down 0.3%

Shares of MD stock opened at $13.37 on Thursday. The stock's 50-day simple moving average is $13.67 and its 200-day simple moving average is $13.97. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.81 and a current ratio of 1.81. The firm has a market capitalization of $1.15 billion, a PE ratio of -13.23, a P/E/G ratio of 0.93 and a beta of 1.27. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The company's revenue was down 7.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.20 earnings per share. Equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on MD. Truist Financial reduced their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Macquarie upped their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Finally, UBS Group reduced their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $16.67.

Get Our Latest Stock Analysis on MD

About Pediatrix Medical Group

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Further Reading

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Pediatrix Medical Group Right Now?

Before you consider Pediatrix Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.

While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines